Omega Healthcare Investors (NYSE:OHI) Issues FY24 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of $2.70-2.80 for the period, compared to the consensus EPS estimate of $2.71.

Omega Healthcare Investors Price Performance

Shares of OHI stock traded up $0.07 during midday trading on Friday, reaching $31.34. 2,470,937 shares of the company traded hands, compared to its average volume of 1,414,371. The firm’s 50 day simple moving average is $30.98 and its two-hundred day simple moving average is $30.97. Omega Healthcare Investors has a 1-year low of $27.53 and a 1-year high of $34.77. The company has a debt-to-equity ratio of 1.35, a current ratio of 6.76 and a quick ratio of 6.76. The firm has a market cap of $7.74 billion, a PE ratio of 28.23, a price-to-earnings-growth ratio of 10.26 and a beta of 0.92.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Tuesday, April 30th will be paid a dividend of $0.67 per share. The ex-dividend date is Monday, April 29th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 8.55%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 241.44%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on OHI shares. Bank of America cut shares of Omega Healthcare Investors from a buy rating to a neutral rating and dropped their price objective for the stock from $33.00 to $31.00 in a research note on Tuesday, January 16th. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $31.00 to $32.00 and gave the stock a hold rating in a research note on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft began coverage on shares of Omega Healthcare Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $36.00 target price for the company. BNP Paribas raised shares of Omega Healthcare Investors from an underperform rating to a neutral rating and set a $30.00 price objective for the company in a research note on Thursday, February 8th. Finally, Citigroup raised shares of Omega Healthcare Investors from a neutral rating to a buy rating and boosted their price objective for the company from $32.00 to $35.00 in a research note on Friday, March 22nd. Seven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Omega Healthcare Investors has a consensus rating of Hold and a consensus price target of $33.63.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.